XML 29 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements Stockholders’ Equity - USD ($)
$ in Thousands
Total
Retirement of Series A
Retirement of Series B
Previously Reported
Retroactive application of recapitalization
Impact of adoption of Topic 606
Common Stock
Common Stock
Retirement of Series A
Common Stock
Retirement of Series B
Common Stock
Previously Reported
Common Stock
Retroactive application of recapitalization
Additional Paid-In Capital
Additional Paid-In Capital
Retirement of Series A
Additional Paid-In Capital
Retirement of Series B
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
Retroactive application of recapitalization
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Deficit
Impact of adoption of Topic 606
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously Reported
Beginning balance (in shares) at Dec. 31, 2018 0     57,571,000 (57,571,000)                                
Beginning balance at Dec. 31, 2018 $ 0     $ 102,006 $ (102,006)                                
Ending balance (in shares) at Dec. 31, 2019 0                                        
Ending balance at Dec. 31, 2019 $ 0                                        
Beginning balance (in shares) at Dec. 31, 2018             62,812,000     5,241,000 57,571,000                    
Beginning balance at Dec. 31, 2018 61,977     $ (40,029) $ 102,006   $ 6     $ 1 $ 5 $ 102,005     $ 4 $ 102,001 $ (39,485) $ (39,485)   $ (549) $ (549)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of common stock upon exercise of stock options (in shares)             226,000                            
Issuance of common stock upon exercise of stock options 90                     90                  
Sale of redeemable convertible preferred stock, net of issuance costs (in shares)             8,862,000                            
Sale of redeemable convertible preferred stock, net of issuance costs 32,561           $ 1         32,560                  
Stock-based compensation expense 644                     644                  
Comprehensive income (loss) (43,574)                               (43,910)     336  
Ending balance (in shares) at Dec. 31, 2019             71,900,000                            
Ending balance at Dec. 31, 2019 $ 51,698         $ 519 $ 7         135,299         (83,395)   $ 519 (213)  
Ending balance (in shares) at Dec. 31, 2020 0                                        
Ending balance at Dec. 31, 2020 $ 0                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of common stock upon exercise of stock options (in shares)             332,000                            
Issuance of common stock upon exercise of stock options 72                     72                  
Sale of redeemable convertible preferred stock, net of issuance costs (in shares)             38,412,000                            
Sale of redeemable convertible preferred stock, net of issuance costs 154,420           $ 4         154,416                  
Retirement of redeemable convertible preferred stock, including deemed dividend (in shares)               (1,543,000) (404,000)                        
Retirement of redeemable convertible preferred stock, including deemed dividend:   $ (1,164) $ (500)                   $ (1,164) $ (500)              
Deemed dividend (6,102)                     (1,815)         (4,287)        
Stock-based compensation expense 1,010                     1,010                  
Comprehensive income (loss) (67,271)                               (67,159)     (112)  
Ending balance (in shares) at Dec. 31, 2020             108,697,000                            
Ending balance at Dec. 31, 2020 $ 132,682           $ 11         287,318         (154,322)     (325)  
Ending balance (in shares) at Dec. 31, 2021 0                                        
Ending balance at Dec. 31, 2021 $ 0                                        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                          
Issuance of common stock upon exercise of stock options (in shares) 913,000           998,000                            
Issuance of common stock upon exercise of stock options $ 713                     713                  
Merger and PIPE Shares, net of transaction costs of $36,770 (in shares)             68,069,000                            
Merger and PIPE Shares, net of transaction costs of $36,770 233,340           $ 7         233,333                  
Conversion of warrants into common stock and issuance of equity classified warrants upon Merger (in shares)             325,000                            
Conversion of warrants into common stock and issuance of equity classified warrants upon Merger 4,576                     4,576                  
Stock-based compensation expense 7,183                     7,183                  
Other (22)                     (22)                  
Comprehensive income (loss) (127,025)                               (126,247)     (778)  
Ending balance (in shares) at Dec. 31, 2021             178,089,000                            
Ending balance at Dec. 31, 2021 $ 251,447           $ 18         $ 533,101         $ (280,569)     $ (1,103)